Patents by Inventor Allan Svendsen

Allan Svendsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11959107
    Abstract: The present invention relates to variants of an alpha-amylase having improved stability to chelating agents relative to its parent enzyme, compositions comprising the variants, nucleic acids encoding the variants, methods of producing the variants, and methods for using the variants.
    Type: Grant
    Filed: August 22, 2022
    Date of Patent: April 16, 2024
    Assignee: Novozymes A/S
    Inventors: Allan Svendsen, Annette Helle Johansen, Mads Bjoernvad, Frank W. Rasmussen, Michael Skjoet, Signe Eskildsen Larsen, Jens Oebro, Svend Kaasgaard, Lars Beier
  • Publication number: 20240084277
    Abstract: The present invention relates to glucoamylase variants having improved thermostability. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 25, 2023
    Publication date: March 14, 2024
    Applicant: Novozymes A/S
    Inventors: Esben Peter Friis, Leonardo De Maria, Jasper Vind, Thomas A. Poulsen, Allan Svendsen, Steffen Danielsen, Rolf T. Lenhard, Henrik Friis-Madsen, Lars K. Skov
  • Patent number: 11840713
    Abstract: The present invention relates to glucoamylase variants having improved thermostability. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: November 10, 2020
    Date of Patent: December 12, 2023
    Assignee: NOVOZYMES A/S
    Inventors: Esben Peter Friis, Leonardo De Maria, Jesper Vind, Thomas A. Poulsen, Allan Svendsen, Steffen Danielsen, Rolf T. Lenhard, Henrik Friis-Madsen, Lars K. Skov
  • Publication number: 20230365953
    Abstract: The present invention relates to variants of an alpha-amylase having improved stability to chelating agents relative to its parent enzyme, compositions comprising the variants, nucleic acids encoding the variants, methods of producing the variants, and methods for using the variants.
    Type: Application
    Filed: June 19, 2023
    Publication date: November 16, 2023
    Applicant: Novozymes A/S
    Inventors: Allan Svendsen, Annette Helle Johansen, Mads Bjoernvad, Frank W. Rasmussen, Michael Skjoet, Signe Eskildsen Larsen, Jens Oebro, Svend Kaasgaard, Lars Beier
  • Publication number: 20230365948
    Abstract: The present invention relates to a variant of a parent lipase, wherein said variant has at least 60% but less than 100% sequence identity with SEQ ID NO: 2; has lipase activity; has substitutions corresponding to G91A and N92D in the lid region located from position G82 to position I100 of SEQ ID NO: 2; has one or more additional substitutions in the lid region; and has at least mutations in positions corresponding to position T231 and position N233 of SEQ ID NO: 2. The present invention also relates to compositions, methods for cleaning a surface using a variant or a composition of the invention; polynucleotides encoding the variants; nucleic acid constructs, vectors, host cells comprising the polynucleotides; methods of using the variants; and methods for obtaining the lipase variant.
    Type: Application
    Filed: June 19, 2023
    Publication date: November 16, 2023
    Applicant: Novozymes A/S
    Inventors: Allan Svendsen, Sune Fang Christensen, Lars Lehman Hylling Christensen, Vikram Kjoller Bhatia, Jesper Vind, Vibeke Skovsgaard Nielsen
  • Patent number: 11795418
    Abstract: The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: June 9, 2021
    Date of Patent: October 24, 2023
    Assignee: Novozymes A/S
    Inventors: Jens Erik Nielsen, Lars Anderson, Allan Svendsen, Rune Nygaard Monrad, Lars Giger, Vasudeva Prahlada Rao, Sohel Dalal, Santhosh Vasu Mepadam, Marie Thrysoe Kruse, Kasper D. Rand, Pernille F. Jensen
  • Patent number: 11725197
    Abstract: The present invention relates to a variant of a parent lipase, wherein said variant has at least 60% but less than 100% sequence identity with SEQ ID NO: 2; has lipase activity; has substitutions corresponding to G91A and N92D in the lid region located from position G82 to position 1100 of SEQ ID NO: 2; has one or more additional substitutions in the lid region; and has at least mutations in positions corresponding to position T231 and position N233 of SEQ ID NO: 2. The present invention also relates to compositions, methods for cleaning a surface using a variant or a composition of the invention; polynucleotides encoding the variants; nucleic acid constructs, vectors, host cells comprising the polynucleotides; methods of using the variants; and methods for obtaining the lipase variant.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: August 15, 2023
    Assignee: Novozymes A/S
    Inventors: Allan Svendsen, Sune Fang Christensen, Lars Lehman Hylling Christensen, Vikram Kjoller Bhatia, Jesper Vind, Vibeke Skovsgaard Nielsen
  • Patent number: 11718840
    Abstract: The present invention relates to variants of a parent alpha-amylase. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: August 8, 2023
    Assignee: NOVOZYMES A/S
    Inventors: Svend Kaasgaard, Signe Eskildsen Larsen, Jens Oebro, Lars Beier, Connie Pontoppidan, Iben Damager, Carsten Andersen, Allan Svendsen
  • Publication number: 20230145736
    Abstract: The present invention relates to xanthan lyase variants and methods for obtaining xanthan lyase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 27, 2022
    Publication date: May 11, 2023
    Applicant: NOVOZYMES A/S
    Inventors: Jens Erik Nielsen, Allan Svendsen, Lars Anderson, Rune Nygaard Monrad, Rajendra Kulothungan Sainathan, Pernille F. Jensen, Kasper D. Rand, Geetha Hiremath Mendez, Sohel Dalal, Shilpi Agarwal
  • Patent number: 11624059
    Abstract: Detergent compositions may include endoglucanase variants and methods of using such detergent compositions. The endoglucanase may have an alteration at one or more positions where the variant has at least 60% but less than 100% sequence identity to SEQ ID NO: 2.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: April 11, 2023
    Assignee: Henkel AG & Co. KGaA
    Inventors: Nina Mussmann, Susanne Wieland, Christian Degering, Rune Nygaard Monrad, Vasudeva P. Rao, Rajendra Kulothungan Sainathan, Sohel Dalal, Santhosh Vasu Mepadam, Allan Svendsen, Mette Louise Dissing Overgaard, Lars Anderson, Geetha Hiremath Mendez
  • Publication number: 20230002748
    Abstract: The present invention relates to variants of an alpha-amylase having improved stability to chelating agents relative to its parent enzyme, compositions comprising the variants, nucleic acids encoding the variants, methods of producing the variants, and methods for using the variants.
    Type: Application
    Filed: August 22, 2022
    Publication date: January 5, 2023
    Applicant: Novozymes A/S
    Inventors: Allan Svendsen, Annette Helle Johansen, Mads Bjoernvad, Frank W. Rasmussen, Michael Skjoet, Signe Eskildsen Larsen, Jens Oebro, Svend Kaasgaard, Lars Beier
  • Publication number: 20220411770
    Abstract: The present invention relates to lipase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: July 6, 2022
    Publication date: December 29, 2022
    Applicant: NOVOZYMES A/S
    Inventors: Miguel Duarte Guilherme Toscano, Allan Svendsen, Jesper Vind, Alexander David Fulton, Lone Baunsgaard
  • Patent number: 11525128
    Abstract: The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: December 13, 2022
    Assignee: Novozymes A/S
    Inventors: Rune Nygaard Monrad, Vasudeva Prahlada Rao, Rajendra Kulothungan Sainathan, Sohel Dalal, VSanthosh Vasu Mepadam, Allan Svendsen, Mette Louise Dissing Overgaard, Lars Andersen, Geetha Hiremath Mendez
  • Patent number: 11512300
    Abstract: The present invention relates to xanthan lyase variants and methods for obtaining xanthan lyase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: November 29, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Jens Erik Nielsen, Allan Svendsen, Lars Anderson, Rune Nygaard Monrad, Rajendra Kulothungan Sainathan, Pernille F. Jensen, Kasper D. Rand, Geetha Hiremath Mendez, Sohel Dalal, Shilpi Agarwal
  • Patent number: 11453868
    Abstract: The present invention relates to variants of an alpha-amylase having improved stability to chelating agents relative to its parent enzyme, compositions comprising the variants, nucleic acids encoding the variants, methods of producing the variants, and methods for using the variants.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: September 27, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Allan Svendsen, Annette Helle Johansen, Mads Bjoernvad, Frank W. Rasmussen, Michael Skjoet, Signe Eskildsen Larsen, Jens Oebro, Svend Kaasgaard, Lars Beier
  • Publication number: 20220213453
    Abstract: The present invention relates to detergent compositions comprising a variant of a parent lipase which variant has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231R+N233R and at least one or more (e.g., several) of D96E, D111A, D254S, G163K, P256T, G91T, and G38A of SEQ ID NO: 2. The present invention also relates to use of the compositions, methods of producing the compositions, and methods of cleaning. The present invention furthermore relates to variants and polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides.
    Type: Application
    Filed: March 22, 2022
    Publication date: July 7, 2022
    Applicant: Novozymes A/S
    Inventors: Marco Malten, Kim Borch, Lise Munch Mikkelsen, Thomas Agersten Poulsen, Luise Erlandsen, Hanne Philbert Nielsen, Carsten Horslev Hansen, Allan Svendsen, Christian Lundager Gylstorff, Jesper Vind, Christian Jackel
  • Patent number: 11371029
    Abstract: The invention relates to a method for generating a preparation of lipase with increased lipolytic activity comprising a step of altering one or more nucleotides in a polynucleotide comprising a first polynucleotide encoding a propeptide operationally linked to a second polynucleotide encoding a lipase, wherein the alteration of one or more nucleotides are made in the first polynucleotide and the alteration independently results in a substitution, an insertion or a deletion in the encoded propeptide amino acid sequence.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: June 28, 2022
    Assignee: Novozymes A/S
    Inventors: Allan Svendsen, Rakhi Saikia, Sohel Dalal, Vikram Kjoeller Bhatia, Lone Baunsgaard
  • Patent number: 11359188
    Abstract: The present invention relates to xanthan lyase variants and methods for obtaining xanthan lyase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: June 14, 2022
    Assignee: Novozymes A/S
    Inventors: Rune Nygaard Monrad, Rajendra Kulothungan Sainathan, Geetha Hiremath Mendez, Sohel Dalal, Shilpi Agarwal, Allan Svendsen, Mette Louise Dissing Overgaard, Vasudeva Prahlada Rao
  • Publication number: 20220145273
    Abstract: The present invention relates to a variant of a parent lipase, which parent lipase has the amino acid sequence of SEQ ID NO: 2, wherein the variant has lipase activity, comprises a substitution at a position corresponding to position 51 and comprises a substitution or remains unaltered at a position corresponding to position 96 of SEQ ID NO: 2. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: January 25, 2022
    Publication date: May 12, 2022
    Applicant: Novozymes A/S
    Inventors: Christian Lundager Gylstorff, Christian Jackel, Jesper Vind, Allan Svendsen, Marco Malten, Thomas Agersten Poulsen
  • Patent number: 11326152
    Abstract: The present invention relates to lipase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: May 10, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Miguel Duarte Guilherme Toscano, Allan Svendsen, Jesper Vind, Alexander David Fulton, Lone Baunsgaard